Journal Article Summary
The article investigates the effects of doxepin, a medication commonly used to treat depression and anxiety, on metabolic health in obese mice. This research is important because while doxepin is effective for mental health conditions, its impact on metabolism, particularly concerning kidney and liver health, remains unclear. Understanding these effects can help inform safer prescribing practices and patient management, especially for those with pre-existing metabolic issues.
In the study, C57BL/6J mice were fed a high-fat diet and treated with doxepin for eight weeks. The results showed that doxepin treatment led to significant weight gain, increased fat accumulation, and worsened glucose intolerance in the mice. Additionally, the treated mice exhibited signs of kidney damage and elevated liver injury markers, indicating that doxepin may exacerbate conditions like nonalcoholic fatty liver disease and renal impairment. The findings suggest that doxepin negatively affects metabolic health by altering glucose homeostasis and increasing fat storage in the liver.
However, the study has limitations, including its focus on animal models, which may not fully translate to human responses. Patients taking doxepin, especially those with obesity or metabolic disorders, should discuss these findings with their healthcare providers. Regular monitoring of blood glucose levels, liver function tests, and kidney health is advisable for those on doxepin to mitigate potential adverse effects and ensure safe treatment outcomes.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Chang Geng-Ruei, Hou Po-Hsun, Yang Wei-Cheng, Wang Chao-Min, Fan Pei-Shan, Liao Huei-Jyuan, Chen To-Pang. Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. Pharmaceuticals 2021. DOI: 10.3390/ph14030267. PMID: 33809508. PMCID: PMC8001117.
Featured Pill Pals Product
Doxepin 10 mg Capsules --- Generic For Sinequan --- Alembic
Doxepin 10 mg Capsules — Generic For Sinequan — Alembic is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
